Terms: = Kidney tumors AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Diagnosis
126 results:
1. Characteristics and Clinical Outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract] [Full Text] [Related]
2. Cancer survivor late-effects, chronic health problems after cancer treatment: what's the evidence from population and registry data and where are the gaps?
Faithfull S; Greenfield D
Curr Opin Support Palliat Care; 2024 Mar; 18(1):55-64. PubMed ID: 38170192
[TBL] [Abstract] [Full Text] [Related]
3. Research on texture images and radiomics in urology: a review of urological MR imaging applications.
Valeri A; Nguyen TA
Curr Opin Urol; 2023 Nov; 33(6):428-436. PubMed ID: 37727910
[TBL] [Abstract] [Full Text] [Related]
4. A spectroscopic liquid biopsy for the earlier detection of multiple cancer types.
Cameron JM; Sala A; Antoniou G; Brennan PM; Butler HJ; Conn JJA; Connal S; Curran T; Hegarty MG; McHardy RG; Orringer D; Palmer DS; Smith BR; Baker MJ
Br J Cancer; 2023 Nov; 129(10):1658-1666. PubMed ID: 37717120
[TBL] [Abstract] [Full Text] [Related]
5. Outcomes of Head and Neck Free Tissue Transfer in Renal Failure Patients.
Oglesby KR; Jefferson GD; Thomas CM; Tomblin C; Alnemri A; Curry JM; Bonaventure C; Sweeny L; Richards HW; Wax M; Kane AC
Laryngoscope; 2024 Feb; 134(2):688-694. PubMed ID: 37449944
[TBL] [Abstract] [Full Text] [Related]
6. A Channel-Dimensional Feature-Reconstructed Deep Learning Model for Predicting Breast Cancer Molecular Subtypes on Overall b-Value Diffusion-Weighted MRI.
Zhou XX; Zhang L; Cui QX; Li H; Sang XQ; Zhang HX; Zhu YM; Kuai ZX
J Magn Reson Imaging; 2024 Apr; 59(4):1425-1435. PubMed ID: 37403945
[TBL] [Abstract] [Full Text] [Related]
7. [Results of the management of kidney cancer with extension into the inferior vena cava: A retrospective, single-center, observational study].
Poirier T; Karam G; Bouchot O; De Vergie S; Branchereau J; Perrouin-Verbe MA; Rigaud J
Prog Urol; 2023 May; 33(6):333-343. PubMed ID: 37076361
[TBL] [Abstract] [Full Text] [Related]
8. Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma.
Fotia G; Stellato M; Guadalupi V; Sepe P; Claps M; Giannatempo P; Bottiglieri A; Rametta A; Taglialatela I; Vela C; Procopio G; Verzoni E
Curr Oncol Rep; 2023 Jun; 25(6):671-677. PubMed ID: 37000341
[TBL] [Abstract] [Full Text] [Related]
9. Outcomes according to treatment using an established protocol in patients with bilateral Wilms' tumor: A national Canadian population-based study.
Bednarek OL; Seemann N; Brzezinski J; Lorenzo A; Fernandez CV; Romao RLP
J Pediatr Surg; 2023 May; 58(5):1014-1017. PubMed ID: 36797114
[TBL] [Abstract] [Full Text] [Related]
10. Current methods facilitating diagnosis of upper tract urothelial carcinoma: a comprehensive literature review.
Krajewski W; Łaszkiewicz J; Nowak Ł; Szydełko T
Curr Opin Urol; 2023 May; 33(3):230-238. PubMed ID: 36727755
[TBL] [Abstract] [Full Text] [Related]
11. Algorithm-Based Approach to the Histological Routine diagnosis of Renal Oncocytic tumors in Core Biopsy Specimens.
Manini C; Imaz I; de Larrinoa AF; López JI
Curr Urol Rep; 2022 Nov; 23(11):327-333. PubMed ID: 36169870
[TBL] [Abstract] [Full Text] [Related]
12. A two-generation hyperparathyroidism-jaw tumor (HPT-JT) syndrome family: clinical presentations, pathological characteristics and genetic analysis: a case report.
Yang D; Zheng J; Tang F; He Q; Huang H; Zhou P
Diagn Pathol; 2022 Sep; 17(1):71. PubMed ID: 36153594
[TBL] [Abstract] [Full Text] [Related]
13. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
Huang S; Hou Y; Hu M; Hu J; Liu X
BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
[TBL] [Abstract] [Full Text] [Related]
14. Molecular uropathology and cancer genetics for the urologist: key findings for classification and diagnosis.
Compérat E; Oszwald A; Wasinger G; Kläger J; Hassler MR; Shariat SF
Curr Opin Urol; 2022 Sep; 32(5):451-455. PubMed ID: 35916009
[TBL] [Abstract] [Full Text] [Related]
15. Immune checkpoint inhibitors and kidney disease.
Wang Q; Moledina DG; Sise ME
Curr Opin Nephrol Hypertens; 2022 Sep; 31(5):449-455. PubMed ID: 35894279
[TBL] [Abstract] [Full Text] [Related]
16. Major heritable renal cell carcinoma syndromes: novel treatment options and future perspectives.
Naidoo V; Perera M; Adam A
Curr Opin Urol; 2022 Sep; 32(5):488-494. PubMed ID: 35855559
[TBL] [Abstract] [Full Text] [Related]
17. Adverse Urinary System Outcomes among Older Women with Endometrial Cancer.
Anderson C; Lund JL; Park J; Brewster W; Bae-Jump V; Olshan AF; Nichols HB
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1508. PubMed ID: 35775217
[TBL] [Abstract] [Full Text] [Related]
18. Papillary renal cell carcinoma: current and controversial issues.
Angori S; Lobo J; Moch H
Curr Opin Urol; 2022 Jul; 32(4):344-351. PubMed ID: 35674688
[TBL] [Abstract] [Full Text] [Related]
19. Renal oncocytoma: a challenging diagnosis.
Mirkheshti N; Farrukh N; Legesse T; Rowe SP; Gordetsky J; Hussain A
Curr Opin Oncol; 2022 May; 34(3):243-252. PubMed ID: 35671122
[TBL] [Abstract] [Full Text] [Related]
20. diagnosis and Treatment of Small Renal Masses: Where Do We Stand?
Tamara JI; Juan GR; Patricia ZJ; Roser VD; Moisés R; Dmitry E; Álvaro SP; Jesús MS
Curr Urol Rep; 2022 Jun; 23(6):99-111. PubMed ID: 35507213
[TBL] [Abstract] [Full Text] [Related]
[Next]
